APGE.D

Apogee Therapeutics, Inc.

Healthcare · Biotechnology

$132.91 sample

+1.04 (+0.79%) 1D

Market cap

$654.9B

Price as of

2026-10-24

Latest filing

8-K · 2026-10-20

Alerts

8

Price$132.91 +2.59% 3M daily closessample

140.64129.56

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 20SEC10-Q filed
Oct 14INSInsider sell: EVP, Operations
Oct 08INSInsider sell: Chief Executive Officer
Oct 02INSInsider sell: Chief Executive Officer
Sep 29SEC8-K filed: material event
Sep 21INSInsider sell: 10% owner
Sep 10INSInsider sell: EVP, Operations
Sep 04INSInsider sell: Chief Financial Officer

Sign up to see the real APGE.D record →

Company facts

SEC EDGAR registration

Name: Apogee Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -49sample, -100 to +100
Reporting currency: USD

Who is positioning in APGE.D

sample

Insiders: 18 insider transactions over 90 days, net selling, $375.7M
Congress: 3 members traded over 90 days
Institutions · 13F: 18 funds hold $7.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$41.8B +16.5% y/y

Q4 2024Q3 2026

Inventory$25.6B +13.9% y/y

Q4 2024Q3 2026

Accounts receivable$18.1B +7.9% y/y

Q4 2024Q3 2026

Total debt$51.3B +9.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $505.8B +12.1% 3M
Sample peer B: $327.1B +6.4% 3M
Sample peer C: $365.8B +14.9% 3M
Sample peer D: $153.4B -4.5% 3M
Sample peer E: $461.3B -4.6% 3M